Petra Sergent

1.5k total citations
10 papers, 1.0k citations indexed

About

Petra Sergent is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Petra Sergent has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Petra Sergent's work include Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Petra Sergent is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Petra Sergent collaborates with scholars based in United States and United Kingdom. Petra Sergent's co-authors include Randolph J. Noelle, Li Wang, J. Louise Lines, Jiannan Li, Wenna Chen, Isabelle Le Mercier, Bo R. Rueda, Anne M. Friel, Rosemary Foster and Michael V. Seiden and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Petra Sergent

10 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Sergent United States 8 750 462 310 182 89 10 1.0k
Marie Christine Wulff Westergaard Denmark 16 602 0.8× 482 1.0× 178 0.6× 75 0.4× 58 0.7× 24 831
Mélanie Desbois France 8 560 0.7× 547 1.2× 310 1.0× 134 0.7× 51 0.6× 16 912
Song Yi Ko United States 15 283 0.4× 358 0.8× 516 1.7× 255 1.4× 109 1.2× 20 948
Wen-Hsuan Yu Taiwan 6 1.0k 1.4× 283 0.6× 801 2.6× 446 2.5× 98 1.1× 8 1.5k
Hocine R. Hocine France 7 468 0.6× 320 0.7× 307 1.0× 152 0.8× 20 0.2× 8 740
Ece Kadioglu Switzerland 7 462 0.6× 355 0.8× 430 1.4× 255 1.4× 21 0.2× 8 883
Stephen P. Santoro United States 6 815 1.1× 603 1.3× 352 1.1× 160 0.9× 20 0.2× 9 1.1k
Shiping Jiao China 6 917 1.2× 401 0.9× 391 1.3× 127 0.7× 94 1.1× 9 1.1k
Paul P. Szotek United States 9 614 0.8× 163 0.4× 667 2.2× 222 1.2× 364 4.1× 9 1.3k
Hillary J. Millar United States 9 356 0.5× 246 0.5× 483 1.6× 150 0.8× 14 0.2× 14 773

Countries citing papers authored by Petra Sergent

Since Specialization
Citations

This map shows the geographic impact of Petra Sergent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Sergent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Sergent more than expected).

Fields of papers citing papers by Petra Sergent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Sergent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Sergent. The network helps show where Petra Sergent may publish in the future.

Co-authorship network of co-authors of Petra Sergent

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Sergent. A scholar is included among the top collaborators of Petra Sergent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Sergent. Petra Sergent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sergent, Petra, et al.. (2018). A Syngeneic Mouse Model of Epithelial Ovarian Cancer Port Site Metastases. Translational Oncology. 12(1). 62–68. 7 indexed citations
2.
Ceeraz, Sabrina, Susan K. Eszterhas, Petra Sergent, et al.. (2017). VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes. Arthritis Research & Therapy. 19(1). 270–270. 42 indexed citations
3.
Ceeraz, Sabrina, Petra Sergent, Alan R. Schned, et al.. (2016). VISTA Deficiency Accelerates the Development of Fatal Murine Lupus Nephritis. Arthritis & Rheumatology. 69(4). 814–825. 57 indexed citations
4.
Mercier, Isabelle Le, Wenna Chen, J. Louise Lines, et al.. (2014). VISTA Regulates the Development of Protective Antitumor Immunity. Cancer Research. 74(7). 1933–1944. 389 indexed citations
5.
He, Lizhi, Vinod Vathipadiekal, Petra Sergent, et al.. (2013). Identification of LMX1B as a novel oncogene in human ovarian cancer. Oncogene. 33(33). 4226–4235. 15 indexed citations
6.
Ceeraz, Sabrina, Petra Sergent, Alan R. Schned, Christopher J. Burns, & Randolph J. Noelle. (2013). Therapeutic role of the novel checkpoint regulator VISTA in murine autoimmune disease models. (P5174). The Journal of Immunology. 190(Supplement_1). 194.4–194.4. 2 indexed citations
7.
Engler, David, Sumeet Gupta, Whitfield B. Growdon, et al.. (2012). Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome. PLoS ONE. 7(2). e30996–e30996. 31 indexed citations
8.
Friel, Anne M., Lingling Zhang, Michael D. Curley, et al.. (2010). Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells. Reproductive Biology and Endocrinology. 8(1). 147–147. 47 indexed citations
9.
Curley, Michael D., Petra Sergent, Carolyn R. Koulouris, et al.. (2009). CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer. Stem Cells. 27(12). 2875–2883. 346 indexed citations
10.
Friel, Anne M., Petra Sergent, Paul P. Szotek, et al.. (2008). Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle. 7(2). 242–249. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026